Aytu BioPharma, Inc. (NASDAQ:AYTU – Get Free Report) shares crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.36 and traded as low as $1.07. Aytu BioPharma shares last traded at $1.07, with a volume of 24,552 shares changing hands.
Aytu BioPharma Stock Down 3.7 %
The stock’s 50-day moving average is $1.35 and its 200-day moving average is $1.69. The company has a current ratio of 0.98, a quick ratio of 0.81 and a debt-to-equity ratio of 0.32. The stock has a market cap of $6.36 million, a P/E ratio of -0.71 and a beta of 0.07.
Aytu BioPharma (NASDAQ:AYTU – Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The company reported ($0.28) earnings per share (EPS) for the quarter. Aytu BioPharma had a negative net margin of 7.62% and a negative return on equity of 19.30%.
About Aytu BioPharma
Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.
Recommended Stories
- Five stocks we like better than Aytu BioPharma
- Stock Market Upgrades: What Are They?
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- How to find penny stocks to invest and trade
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Aytu BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aytu BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
